| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Pia Vihinen | Q57400959 |
| P2093 | author name string | Veli-Matti Kähäri | |
| P2860 | cites work | Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members | Q22001456 |
| Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution | Q24317893 | ||
| Furin-dependent intracellular activation of the human stromelysin-3 zymogen | Q28115242 | ||
| A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas | Q28116420 | ||
| Tissue inhibitors of metalloproteinases: evolution, structure and function | Q28138083 | ||
| Matrix metalloproteinases | Q28140451 | ||
| Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis | Q28140740 | ||
| Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense | Q28145389 | ||
| Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials | Q28369525 | ||
| Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin | Q28589898 | ||
| Matrix metalloproteinase degradation of extracellular matrix: biological consequences | Q28611041 | ||
| Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis | Q30697267 | ||
| Development of matrix metalloproteinase inhibitors in cancer therapy. | Q31832006 | ||
| Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3). | Q31922966 | ||
| Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen | Q33177387 | ||
| Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors. | Q33270666 | ||
| Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies | Q33331110 | ||
| Matrix metalloproteinases and their inhibitors in tumour growth and invasion | Q33603385 | ||
| Promising new developments in cancer chemotherapy | Q33651996 | ||
| Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
| Matrix metalloproteinases: biologic activity and clinical implications | Q33849967 | ||
| Matrix metalloproteinase inhibitors: applications in oncology. | Q33888231 | ||
| Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis | Q34013787 | ||
| Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment | Q34293595 | ||
| Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. | Q34307809 | ||
| Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins | Q34479986 | ||
| Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas | Q34497741 | ||
| Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness | Q35360505 | ||
| Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I | Q35669086 | ||
| Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. | Q35745256 | ||
| Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma | Q35746324 | ||
| Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor | Q35753232 | ||
| Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma | Q36135756 | ||
| In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy | Q36255141 | ||
| Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer | Q36291671 | ||
| Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage | Q36431093 | ||
| Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas | Q36617718 | ||
| The clinical significance of MMP-1 expression in oesophageal carcinoma | Q36622489 | ||
| Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma | Q36623544 | ||
| Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. | Q36836819 | ||
| Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis | Q37230996 | ||
| Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer | Q40608619 | ||
| Ongoing trials with matrix metalloproteinase inhibitors | Q40740781 | ||
| MMP inhibition and downregulation by bisphosphonates. | Q40804689 | ||
| Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer | Q40875227 | ||
| Progelatinase A mRNA expression in cell lines derived from tumors in patients with metastatic renal cell carcinoma correlates inversely with survival | Q41097692 | ||
| Role of matrix metalloproteinases in abdominal aortic aneurysms | Q41261468 | ||
| Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors | Q42439334 | ||
| Human collagenase-3 is expressed in malignant squamous epithelium of the skin | Q42442111 | ||
| Reversible sideroblastic anemia associated with the tetracycline analogue COL-3. | Q43560616 | ||
| Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder | Q43601092 | ||
| Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial | Q43693195 | ||
| High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma | Q43861059 | ||
| Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression. | Q43912549 | ||
| Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma? | Q44901177 | ||
| Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer | Q47976225 | ||
| Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma. | Q50849840 | ||
| Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation. | Q53425886 | ||
| Expression and Prognostic Significance of Metalloproteinases and Their Tissue Inhibitors in Patients With Small-Cell Lung Cancer | Q57272687 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 157-166 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets | |
| P478 | volume | 99 |
| Q38009800 | A complete compilation of matrix metalloproteinase expression in human malignant gliomas. |
| Q37064899 | A known expressed sequence tag, BM742401, is a potent lincRNA inhibiting cancer metastasis |
| Q37316568 | A novel organotypic model mimics the tumor microenvironment |
| Q64890617 | A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential. |
| Q28201376 | ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165 |
| Q33289231 | Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ). |
| Q28185337 | Active stromelysin-3 (MMP-11) increases MCF-7 survival in three-dimensional Matrigel culture via activation of p42/p44 MAP-kinase |
| Q38180339 | Advances in NKG2D ligand recognition and responses by NK cells |
| Q38453906 | Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours. Part 2: invasion, angiogenesis, metastasis and therapy |
| Q39652187 | An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines |
| Q36199836 | Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinoma |
| Q35160210 | Angiogenic tumor markers, antiangiogenic agents and radiation therapy |
| Q28385365 | Anthocyanins from Vitis coignetiae Pulliat Inhibit Cancer Invasion and Epithelial-Mesenchymal Transition, but These Effects Can Be Attenuated by Tumor Necrosis Factor in Human Uterine Cervical Cancer HeLa Cells |
| Q35214281 | Anti-angiogenesis in cancer therapy |
| Q39014524 | Anti-metastatic effect of supercritical extracts from the Citrus hassaku pericarp via inhibition of C-X-C chemokine receptor type 4 (CXCR4) and matrix metalloproteinase-9 (MMP-9). |
| Q39793510 | Antimetastatic activity of MONCPT in preclinical melanoma mice model |
| Q39304192 | Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9. |
| Q37591742 | Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer |
| Q36407244 | Antiprotease therapy in cancer: hot or not? |
| Q39212676 | Antisense MMP-9 RNA inhibits malignant glioma cell growth in vitro and in vivo |
| Q51040887 | Antitumoral Effects of D-Fraction from Grifola Frondosa (Maitake) Mushroom in Breast Cancer. |
| Q64104358 | Antrodin C, an NADPH Dependent Metabolism, Encourages Crosstalk between Autophagy and Apoptosis in Lung Carcinoma Cells by Use of an AMPK Inhibition-Independent Blockade of the Akt/mTOR Pathway |
| Q81513305 | Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer |
| Q43963068 | Associations between high levels of Notch1 expression and high invasion and poor overall survival in hepatocellular carcinoma |
| Q46849209 | Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes. |
| Q35952331 | Biopolymeric agents for skin wrinkle treatment |
| Q36334889 | Bladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets |
| Q58455528 | Blastema induction in aneurogenic state and Prrx-1 regulation by MMPs and FGFs in Ambystoma mexicanum limb regeneration |
| Q41455503 | Blood Droplet-Based Cancer Diagnosis via Proteolytic Activity Measurement in Cancer Progression. |
| Q34155848 | Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis |
| Q40682618 | Bradykinin antagonists as new drugs for prostate cancer |
| Q80573664 | CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma |
| Q41636608 | Cancer cells remodel themselves and vasculature to overcome the endothelial barrier. |
| Q38154977 | Cancer development, progression, and therapy: an epigenetic overview. |
| Q37282934 | Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer. |
| Q39098398 | CellMinerHCC: a microarray-based expression database for hepatocellular carcinoma cell lines. |
| Q50879774 | Characterization of MicroRNA Expression Profiles in Patients with Giant Cell Tumor. |
| Q34284580 | Chemical proteomics: terra incognita for novel drug target profiling |
| Q35574109 | Chemokines: key players in cancer |
| Q35870243 | Ciliary body melanoma: a special challenge. |
| Q48032593 | Circulating matrix metalloproteinase-9 is transiently elevated after colorectal surgery. |
| Q48923618 | Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas |
| Q34604748 | Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma |
| Q40491812 | Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing |
| Q40596151 | Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4'-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4'-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamide |
| Q40601081 | Comparative studies on the secretion and activation of MMPs in two reconstructed human skin models using HaCaT- and HaCaT-ras-transfected cell lines |
| Q33233386 | Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma |
| Q39626106 | Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression |
| Q28167125 | Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer |
| Q42804834 | Differential effects of trichostatin A on gelatinase A expression in 3T3 fibroblasts and HT-1080 fibrosarcoma cells: implications for use of TSA in cancer therapy |
| Q34325639 | Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer |
| Q38999131 | Down-regulation of Gli-1 inhibits hepatocellular carcinoma cell migration and invasion |
| Q82981403 | E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients |
| Q33858538 | EGFR may couple moderate alcohol consumption to increased breast cancer risk. |
| Q39421899 | EMMPRIN contributes to the in vitro invasion of human salivary adenoid cystic carcinoma cells |
| Q39422403 | EMMPRIN silencing inhibits proliferation and perineural invasion of human salivary adenoid cystic carcinoma cells in vitro and in vivo |
| Q42229992 | Effective nanoparticle-based gene delivery by a protease triggered charge switch |
| Q33598470 | Effects of RNA silencing of matrix metalloproteinase-2 on the growth of esophageal carcinoma cells in vivo |
| Q39481861 | Effects of RNAi-mediated matrix metalloproteinase-2 gene silencing on the invasiveness and adhesion of esophageal carcinoma cells, KYSE150. |
| Q83314051 | Effects of standard treatment on the dynamics of matrix metalloproteinases gene expression in patients with acute coronary syndromes |
| Q38784161 | Efficient and Accurate Algorithm for Cleaved Fragments Prediction (CFPA) in Protein Sequences Dataset Based on Consensus and Its Variants: A Novel Degradomics Prediction Application. |
| Q43807904 | Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer |
| Q38782304 | Embelin Inhibits Invasion and Migration of MDA-MB-231 Breast Cancer Cells by Suppression of CXC Chemokine Receptor 4, Matrix Metalloproteinases-9/2, and Epithelial-Mesenchymal Transition |
| Q37799614 | Enzyme-triggered nanomedicine: drug release strategies in cancer therapy. |
| Q39777910 | Equine sarcoid fibroblasts over-express matrix metalloproteinases and are invasive |
| Q89805613 | Esophageal Cancer Development: Crucial Clues Arising from the Extracellular Matrix |
| Q51097581 | Expression and Purification of Matrix Metalloproteinases in Escherichia coli. |
| Q57758506 | Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma |
| Q36014448 | Expression of CD147, PCNA, VEGF, MMPs and their clinical significance in the giant cell tumor of bones. |
| Q37719954 | Expression of RECK and MMP-2 in salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis |
| Q42437433 | Expression of extracellular matrix metalloproteinase inducer in odontogenic cysts |
| Q37145151 | Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas |
| Q38443170 | Expression of matrix metalloproteinase-10 in human bladder transitional cell carcinoma. |
| Q73507201 | Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer |
| Q83275383 | Expression of matrix metalloproteinases (MMP-2 and MMP-9) in recurrent respiratory papillomas and laryngeal carcinoma: clinical and morphological parallels |
| Q24652514 | Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature |
| Q53309145 | Expression of membrane type 1 matrix metalloproteinase in medullary thyroid carcinoma: prognostic implications. |
| Q47662103 | Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity |
| Q38225316 | Extracellular acidity, a "reappreciated" trait of tumor environment driving malignancy: perspectives in diagnosis and therapy. |
| Q39735864 | FAK is involved in invasion and metastasis of hepatocellular carcinoma |
| Q37701605 | Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma |
| Q37225152 | Flavonoids from Orostachys japonicus A. Berger inhibit the invasion of LnCaP prostate carcinoma cells by inactivating Akt and modulating tight junctions |
| Q38867211 | FoxM1 influences mouse hepatocellular carcinoma metastasis in vitro |
| Q40736375 | Frequency of the common promoter polymorphism MMP2 -1306 C>T in a population from central Bulgaria |
| Q40572870 | Functional significance of metastasis-inducing S100A4(Mts1) in tumor-stroma interplay |
| Q42453573 | Gadd45a regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation |
| Q38798293 | Gefitinib ('Iressa', ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2. |
| Q36591329 | Gene expression and gene therapy imaging |
| Q37000933 | Gene expression profiling analysis of ovarian cancer |
| Q36908209 | Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome |
| Q36072604 | Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and development |
| Q35175978 | GnT-V, macrophage and cancer metastasis: a common link |
| Q24337919 | Golgi reassembly stacking protein 55 interacts with membrane-type (MT) 1-matrix metalloprotease (MMP) and furin and plays a role in the activation of the MT1-MMP zymogen |
| Q50721751 | Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. |
| Q42770577 | Growth differentiation factor-15 as a prognostic biomarker in cancer patients |
| Q92341877 | High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme |
| Q64325220 | Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis |
| Q40696400 | IL-1beta induces MMP-9 via reactive oxygen species and NF-kappaB in murine macrophage RAW 264.7 cells |
| Q90169804 | Increasing the low lipid phosphate phosphatase 1 activity in breast cancer cells decreases transcription by AP-1 and expressions of matrix metalloproteinases and cyclin D1/D3 |
| Q28270932 | Individual cell-based models of tumor-environment interactions: Multiple effects of CD97 on tumor invasion |
| Q46674962 | Induction of multicellular 3-D spheroids of MCF-7 breast carcinoma cells by neutrophil-derived cathepsin G and elastase |
| Q34169904 | Inflammatory transcriptome profiling of human monocytes exposed acutely to cigarette smoke. |
| Q29617534 | Influence of tumour micro-environment heterogeneity on therapeutic response |
| Q34293732 | Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. |
| Q40295186 | Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones |
| Q38827093 | Inhibition of pancreatic cancer cell migration by plasma anthocyanins isolated from healthy volunteers receiving an anthocyanin-rich berry juice |
| Q40038750 | Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma |
| Q92839737 | Invasion of TC-1 cells to skeletal muscle fibers protect them from peroxisomicine A1 (T-514) treatment in a murine model of cancer |
| Q40742201 | Investigation of the role of MMP3 -1171insA polymorphism in cutaneous malignant melanoma - a preliminary study |
| Q33980773 | Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells |
| Q54411176 | Is a single nucleotide polymorphism a risk factor for lung cancer in the matrix metalloproteinase-2 promoter? |
| Q35914351 | Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases |
| Q47118618 | Knocking-out matrix metalloproteinase-13 exacerbates rotator cuff muscle fatty infiltration |
| Q39333491 | LEF-1 regulates proliferation and MMP-7 transcription in breast cancer cells |
| Q48103478 | Leptin induces matrix metalloproteinase 7 expression to promote ovarian cancer cell invasion by activating ERK and JNK pathways. |
| Q38778459 | Liprin-α1 is a regulator of vimentin intermediate filament network in the cancer cell adhesion machinery |
| Q38948146 | Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells†. |
| Q35157568 | Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future? |
| Q33991012 | MMP-1 expression has an independent prognostic value in breast cancer |
| Q34997415 | MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas. |
| Q51771129 | MMP-14 can serve as a prognostic marker in patients with supraglottic cancer. |
| Q36181497 | MMP1-1607(1G>2G) polymorphism and the risk of lung cancer in Lebanon |
| Q33947759 | MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma |
| Q37875004 | MRI & MRS assessment of the role of the tumour microenvironment in response to therapy. |
| Q38906918 | Mapping intermolecular interactions and active site conformations: from human MMP-1 crystal structure to molecular dynamics free energy calculations |
| Q47235743 | Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease. |
| Q37142364 | Matrix metalloproteinase 13 is a new contributor to skeletal muscle regeneration and critical for myoblast migration |
| Q33638905 | Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue. |
| Q73437447 | Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma |
| Q40679183 | Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. |
| Q35005158 | Matrix metalloproteinase-9 expression by Hodgkin-Reed-Sternberg cells is associated with reduced overall survival in young adult patients with classical Hodgkin lymphoma |
| Q39308148 | Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion |
| Q45363258 | Matrix metalloproteinase-9 is consistently expressed in Hodgkin/Reed-Sternberg cells and has no impact on survival in patients with Epstein-Barr virus (EBV)-related and non-related Hodgkin lymphoma in Brazil |
| Q38793764 | Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs |
| Q81864212 | Matrix metalloproteinases and angiogenesis |
| Q37864524 | Matrix metalloproteinases and their clinical relevance in urinary bladder cancer |
| Q54649706 | Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma. |
| Q99637911 | Matrix metalloproteinases in keratinocyte carcinomas |
| Q35110130 | Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. |
| Q24795980 | Matrix metalloproteinases: old dogs with new tricks |
| Q39388493 | Matrix metalloproteinases: their functional role in lung cancer |
| Q37876089 | Mechanisms of tumor and viral immune escape from natural killer cell-mediated surveillance |
| Q35587684 | Membrane associated proteases and their inhibitors in tumour angiogenesis |
| Q41613641 | Membranous type matrix metalloproteinase 16 induces human prostate cancer metastasis |
| Q26771838 | Meta-analysis of association of the matrix metalloproteinase 2 (-735 C/T) polymorphism with cancer risk |
| Q48022654 | Metalloproteinase-2 expression correlates with aggressiveness of cutaneous squamous cell carcinomas |
| Q51416828 | Metastasis in context: modeling the tumor microenvironment with cancer-on-a-chip approaches. |
| Q90277578 | MicroRNA-488 inhibits proliferation, invasion and EMT in osteosarcoma cell lines by targeting aquaporin 3 |
| Q89516757 | MicroRNA-96-5p promotes proliferation, invasion and EMT of oral carcinoma cells by directly targeting FOXF2 |
| Q51128003 | Molecular dynamics simulation study on the interaction of collagen-like peptides with gelatinase-A (MMP-2). |
| Q33562717 | Molecular events associated with epithelial to mesenchymal transition of nasopharyngeal carcinoma cells in the absence of Epstein-Barr virus genome |
| Q36037512 | Molecular pathways in bladder cancer: part 2. |
| Q37189400 | Molecular prognostic factors in penile cancer |
| Q41661199 | Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives |
| Q36089228 | Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways |
| Q39687487 | Nitric oxide-mediated invasion in Barrett's high-grade dysplasia and adenocarcinoma. |
| Q39680014 | Nitrogen-containing bisphosphonate, YM529/ONO-5920, inhibits tumor metastasis in mouse melanoma through suppression of the Rho/ROCK pathway |
| Q35911132 | Novel targets for the treatment of endometriosis |
| Q39646679 | Organ specific regulation of tumour invasiveness and gelatinolytic activity at the invasive front |
| Q48125956 | Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases. |
| Q33778640 | Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer |
| Q59101042 | Overexpression of MMP13 is associated with clinical outcomes and poor prognosis in oral squamous cell carcinoma |
| Q55457211 | Overexpression of miR-1283 inhibits cell proliferation and invasion of glioma cells by targeting ATF4. |
| Q39493165 | PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo |
| Q33638953 | Peptide aptamers as new tools to modulate clathrin-mediated internalisation--inhibition of MT1-MMP internalisation |
| Q35783096 | Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates |
| Q38201795 | Pigment epithelium-derived factor as a natural matrix metalloproteinase inhibitor: a comparison with classical matrix metalloproteinase inhibitors used for cancer treatment |
| Q36777285 | Positron emission tomography tracers for imaging angiogenesis |
| Q39987613 | Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway |
| Q34256198 | Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM) |
| Q36846821 | Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs |
| Q39969637 | Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells. |
| Q38908279 | Profile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in Colorectal Cancer: Assessment of the Role in Diagnosis and Prognostication |
| Q53318912 | Prognostic factors and biomarkers of penile carcinoma. |
| Q50993561 | Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer. |
| Q54379440 | Prognostic significance of matrix metalloproteinase-20 overexpression in laryngeal squamous cell carcinoma. |
| Q35616512 | Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis |
| Q79224554 | Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer |
| Q57163075 | Protease activity as a prognostic factor for wound healing in venous leg ulcers |
| Q58305365 | Protease activity as a prognostic factor for wound healing in venous leg ulcers |
| Q38050990 | Protein and non-protein biomarkers in melanoma: a critical update |
| Q33820267 | Protein secretion in human mammary epithelial cells following HER1 receptor activation: influence of HER2 and HER3 expression |
| Q37821301 | Proteinases and their inhibitors in liver cancer |
| Q37629015 | Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer |
| Q34289671 | QM/MM Studies of the Matrix Metalloproteinase 2 (MMP2) Inhibition Mechanism of (S)-SB-3CT and its Oxirane Analogue |
| Q33946429 | RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro |
| Q59341188 | Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications |
| Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
| Q34770095 | Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein |
| Q80481862 | Relationship between matrix metalloproteinase 2 and lung cancer progression |
| Q47967469 | Relationship of 99mTc-HYNIC annexin V uptake to microvessel density, FasL and MMP-9 expression, and the number of tumour-infiltrating lymphocytes in head and neck carcinoma |
| Q50335893 | Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells |
| Q35217698 | Role of cancer cell-stroma interaction in invasive growth of cancer cells |
| Q37699403 | S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac. |
| Q37692836 | Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients |
| Q45305261 | Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma |
| Q99617219 | Silencing glioma-associated oncogene homolog 1 suppresses the migration and invasion of hepatocellular carcinoma in vitro |
| Q39195401 | Simulated microgravity alters the metastatic potential of a human lung adenocarcinoma cell line |
| Q24650885 | Studies on anticancer activities of antimicrobial peptides |
| Q58796710 | Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1 |
| Q34391559 | Surfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasis |
| Q35167925 | Surrogate markers in antiangiogenesis clinical trials |
| Q33632650 | Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions |
| Q44472706 | Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents |
| Q35016398 | Systemic delivery of protein nanocages bearing CTT peptides for enhanced imaging of MMP-2 expression in metastatic tumor models |
| Q37294488 | TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions. |
| Q59793832 | TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis |
| Q91779675 | TIMP-2 inhibits metastasis and predicts prognosis of colorectal cancer via regulating MMP-9 |
| Q36956724 | Tackling EGFR signaling with TACE antagonists: a rational target for metalloprotease inhibitors in cancer |
| Q45234886 | Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo |
| Q35760031 | Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas |
| Q81140846 | Temporospatial expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in mouse antigen-induced arthritis |
| Q40375589 | Tetracycline analogues (doxycycline and COL-3) induce caspase-dependent and -independent apoptosis in human colon cancer cells |
| Q57817849 | The Antitumor Properties of the α3(IV)-(185-203) Peptide from the NC1 Domain of Type IV Collagen (Tumstatin) Are Conformation-dependent |
| Q99614944 | The Product of Matrix Metalloproteinase Cleavage of Doxorubicin Conjugate for Anticancer Drug Delivery: Calorimetric, Spectroscopic, and Molecular Dynamics Studies on Peptide-Doxorubicin Binding to DNA |
| Q39195025 | The acidic microenvironment as a possible niche of dormant tumor cells. |
| Q46328640 | The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma. |
| Q34084897 | The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients |
| Q39380237 | The effect of inositol hexaphosphate on the expression of selected metalloproteinases and their tissue inhibitors in IL-1β-stimulated colon cancer cells. |
| Q51742979 | The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer |
| Q24671121 | The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression |
| Q36593636 | The impact of aryl hydrocarbon receptor signaling on matrix metabolism: implications for development and disease |
| Q35012821 | The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis |
| Q35793635 | The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration. |
| Q38211072 | The role of inflammation in lung cancer. |
| Q38974714 | The roles of microRNAs related with progression and metastasis in human cancers. |
| Q41779392 | Tissue factor pathway inhibitor-2 inhibits the growth and invasion of hepatocellular carcinoma cells and is inactivated in human hepatocellular carcinoma |
| Q50110755 | Towards an MMP-2-activated molecular agent for cancer imaging |
| Q40011557 | Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas. |
| Q83339211 | Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas |
| Q40620337 | Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system |
| Q39876136 | Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion |
| Q35015430 | Translationally controlled tumor protein induces epithelial to mesenchymal transition and promotes cell migration, invasion and metastasis |
| Q41831790 | Transplantation with bone marrow stromal cells promotes wound healing under chemotherapy through altering phenotypes |
| Q42809444 | Trichostatin A-histone deacetylase inhibitor with clinical therapeutic potential-is also a selective and potent inhibitor of gelatinase A expression |
| Q53496509 | Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells. |
| Q59591359 | Tumorstroma interactions: their role in the control of tumor cell invasion and metastasis |
| Q37060284 | Tumour endoproteases: the cutting edge of cancer drug delivery? |
| Q33233428 | Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator |
| Q34348691 | Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers |
| Q38124850 | Understanding the pathogenesis of endometriosis through proteomics: recent advances and future prospects |
| Q38851330 | Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways |
| Q36234720 | Urothelial tumorigenesis: a tale of divergent pathways |
| Q33820717 | Viral oncolysis - can insights from measles be transferred to canine distemper virus? |
| Q82908240 | [The physiopathology of metastases: from primary to secondary] |
| Q35023269 | miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells |
| Q90404365 | miR-4792 inhibits acute myeloid leukemia cells proliferation and invasion, and promotes cells apoptosis by targeting Kindlin-3 |
| Q40164005 | p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells |
| Q35207239 | siRNA suppression of hTERT using activatable cell-penetrating peptides in hepatoma cells |
| Q35713784 | uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells |
Search more.